SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,155,616 | -28.9% | 93,236 | -19.4% | 0.05% | -43.8% |
| Q2 2023 | $3,031,897 | +18.3% | 115,633 | +16.1% | 0.10% | +21.5% |
| Q1 2023 | $2,563,189 | -99.9% | 99,580 | +10.7% | 0.08% | +61.2% |
| Q3 2022 | $2,568,000,000 | +28.0% | 89,993 | +10.4% | 0.05% | +69.0% |
| Q2 2022 | $2,006,000,000 | – | 81,493 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |